Actively Recruiting
Feasibility Study of Accelerated Intermittent Theta Burst Stimulation for Depression in PTSD
Led by Lawson Research Institute of St. Joseph's · Updated on 2026-09-18
16
Participants Needed
1
Research Sites
13 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating accelerated intermittent theta burst stimulation iTBS, a non-invasive magnetic brain stimulation, in adults with both post-traumatic stress disorder PTSD and major depressive disorder MDD. This pilot feasibility study aims to determine if a faster brain stimulation schedule is practical, safe, tolerable, and acceptable when delivered in a clinical setting. The study also explores changes in depression, PTSD, anxiety symptoms, quality of life, and brain activity over time. Participants will receive active accelerated iTBS consisting of six short brain stimulation sessions per day over five consecutive days, totaling 30 sessions. This treatment is delivered to the left dorsolateral prefrontal cortex using a transcranial magnetic stimulation system. The study is single-arm and open-label, involving about 12 to 16 participants who will all receive the active intervention. During the study, participants will undergo health screening and baseline assessments before treatment. Brain activity will be measured using EEG recordings at baseline and during treatment. Follow-up assessments will occur at Week 2, Week 5, and Week 12 to monitor symptoms, functioning, quality of life, treatment adherence, safety, and participant satisfaction. The total participation duration extends through 12 weeks after treatment.
CONDITIONS
Brief Title
Accelerated iTBS for PTSD and Depression
Research Team
R
Radhika Kelkar, MD
M
Mervin Blair, PhD, C.Psych
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here